| 14:00 | Introduction | WILLEKENS K | ||
| 14:05 | New legislation for the orthoptist: clinical and organizational impact of screening, diagnosis and treatment | VAN NUFFEL S | ||
| 14:30 | Intermezzo: myopia control in Belgium | DELBEKE P | ||
| 14:35 | Intravitreal Injection Therapy: Clinical Innovation, Reimbursement and Sustainability | GOETHALS S | ||
| 14:50 | Nomenclature, Reimbursement and Transparency codes: Ethical and Economic Perspectives | WILLEKENS K | ||
| 15:25 | Questions | |||
| 15:30 | End of Session | |||